1. Systemic and Coronary Hemodynamic Effects of Vasopressin
- Author
-
David H. McKenna, George S. O'brien, George G. Rowe, Corliss Rj, and Sialer S
- Subjects
Cardiac output ,medicine.medical_specialty ,Vasopressin ,Vasopressins ,Blood Pressure ,Body weight ,Cardiovascular System ,Dogs ,Oxygen Consumption ,Heart Rate ,Internal medicine ,Bradycardia ,medicine ,Animals ,Vasoconstrictor Agents ,Cardiac Output ,Hypoxia ,Hemodynamic effects ,business.industry ,Myocardium ,Respiration ,Hemodynamics ,Blood Pressure Determination ,Heart ,General Medicine ,Blood flow ,Peripheral ,Oxygen ,Blood pressure ,medicine.anatomical_structure ,Injections, Intravenous ,Lactates ,Cardiology ,Vascular resistance ,Vascular Resistance ,business - Abstract
In the intact, anesthetized dog, an intravenous infusion of 0.02 U/kg body weight/min of Vasopressin increased the total peripheral, pulmonary, and coronary vascular resistance and decreased coronary blood flow and cardiac output There was a slight increase in systemic arterial blood pressure, A dec
- Published
- 1968
- Full Text
- View/download PDF